If you've applied for the Emcure Pharmaceuticals Ltd IPO,
you're likely eager to know the allocation status. Well,
the wait is over! The allotment process has been
completed, and now you can easily check how many shares
you've been allotted. You can do this by visiting the
Link Intime India Pvt Ltd registrar website. Moreover,
for those who didn't receive an allotment, rest assured,
the refund process has also been finalized.
The allotment date for the Emcure Pharmaceuticals Ltd IPO
has been confirmed, and allotments have been finalized.
Investors who applied for the issue can now verify their
allotment status on the registrar portal designated for
Emcure Pharmaceuticals Ltd IPO, managed by Link Intime India Pvt Ltd. You can discover the number of shares allotted
to you through the registrar's website. Additionally,
the company has concluded the refund process for
investors who were not allotted shares. The subscription
period for Emcure Pharmaceuticals Ltd IPO commenced on July 3, 2024, and concluded on July 5, 2024.
On the third day of subscription, the Emcure Pharmaceuticals Ltd IPO witnessed 0.19 times subscription. The listing date is
scheduled on July 10, 2024. Investors can ascertain
their share allocation through the basis of allotment
process and check their allotment status. For those who
were not allocated shares, the refund process will
commence on July 9, 2024. Those allotted shares will
receive them in their demat accounts on July 9, 2024.
The listing date for Emcure Pharmaceuticals Ltd IPO is
confirmed to be July 10, 2024.
If you've applied for the Emcure Pharmaceuticals Ltd IPO,
you can easily check your allotment status on the Link Intime India Pvt Ltd website. Here's a simple guide to
check your allotment status:
- Go to the Link Intime India Pvt Ltd website.
-
Select the Emcure Pharmaceuticals Ltd IPO from the
dropdown menu.
-
Choose either your Application Number, Demat
Account, or PAN to proceed.
-
Select your application type as ASBA or non-ASBA.
-
Provide the required details based on your selection
in the previous step.
- Complete the Captcha verification.
-
Click on the submit button to view your allotment
status.
-
Navigate to the allotment page on the official BSE
website via this link:
https://www.bseindia.com/investors/appli_check.aspx
-
In the 'Issue Type' section, opt for 'Equity' and
pick the Emcure Pharmaceuticals Ltd IPO from the
dropdown menu labeled 'Issue Name'.
-
Enter either your PAN or application number, then
click the 'Submit' button.
-
to NSE's official website using this
link:https://www.nseindia.com/
-
Choose the 'Click here to sign up' option and
complete the registration process using your PAN
details.
-
Enter your username, password, and captcha code on
the subsequent page.
-
Once logged in, navigate to the designated section
to check the IPO allotment status.
The following table outlines the allocation quotas for
different categories, detailing both the number of
shares and the percentage of the total share capital
raised. However, it's primarily the quotas for retail
and HNI investors that are of significant interest.
Category of Investors |
Allocation of shares under IPO
|
Reservation for Employees |
1,08,900 (0.56%) |
Anchor Allocation |
57,76,934 (29.83%) |
QIB Shares Offered |
38,51,290 (19.89%) |
NII (HNI) Shares Offered |
28,88,467 (14.92%) |
Retail Shares Offered |
67,39,756 (34.8%) |
Total Shares Offered |
1,93,65,348 |
Data Source: BSE, NSE
Let's now examine how different categories of investors
participated in placing their bids for the IPO of Emcure Pharmaceuticals Ltd.
Next, let's delve into the level of subscription. The
table below illustrates the degree of subscription for
each category, along with the overall subscription for
Emcure Pharmaceuticals Ltd.
Category |
Subscription Status |
Qualified Institutional Buyers (QIB) |
0x |
S (HNI) ₹2 lakhs to ₹10 lakhs |
[-] |
B (HNI) Above ₹10 lakhs |
[-] |
Non Institutional Investors (NII) |
0.3x |
Retail Individuals |
0.25x |
Employees |
[-] |
Overall Subscription |
0.19x |
Data Source: BSE, NSE
The QIB portion witnessed a
subscription of 0 times, while the HNI/NII portion
saw a subscription of 0.3 times. The Retail portion
experienced a subscription of 0.25 times, culminating in
an overall subscription of 0.19 times for the IPO.